These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9230468)

  • 21. Stabilization of the biologically active conformation of the principal neutralizing determinant of HIV-1(IIIB) containing a cis-proline surrogate: 1H NMR and molecular modeling study.
    Garcia J; Dumy P; Rosen O; Anglister J
    Biochemistry; 2006 Apr; 45(13):4284-94. PubMed ID: 16566603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site.
    Ghiara JB; Ferguson DC; Satterthwait AC; Dyson HJ; Wilson IA
    J Mol Biol; 1997 Feb; 266(1):31-9. PubMed ID: 9054968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solution conformation of a peptide corresponding to the principal neutralizing determinant of HIV-1IIIB: a two-dimensional NMR study.
    Zvi A; Hiller R; Anglister J
    Biochemistry; 1992 Aug; 31(30):6972-9. PubMed ID: 1637831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The principal neutralizing determinant of HIV-1 located in V3 of gp120 forms a 12-residue loop by internal hydrophobic interactions.
    Zvi A; Kustanovich I; Hayek Y; Matsushita S; Anglister J
    FEBS Lett; 1995 Jul; 368(2):267-70. PubMed ID: 7543061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Theoretical study of peptide spatial structure--fragments of the base antigenic determinant of HIV-1 gp120 protein. I. Peptides rp142 and rp342].
    Andrianov AM
    Mol Biol (Mosk); 1997; 31(5):861-71. PubMed ID: 9454072
    [No Abstract]   [Full Text] [Related]  

  • 26. Structural comparison of a 15 residue peptide from the V3 loop of HIV-1IIIb and an O-glycosylated analogue.
    Huang X; Smith MC; Berzofsky JA; Barchi JJ
    FEBS Lett; 1996 Sep; 393(2-3):280-6. PubMed ID: 8814305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NMR studies on the conformation of the CD4 36-59 peptide bound to HIV-1 gp120.
    Gizachew D; Moffett DB; Busse SC; Westler WM; Dratz EA; Teintze M
    Biochemistry; 1998 Jul; 37(30):10616-25. PubMed ID: 9692951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Spatial structure of the rp142 peptide containing the immunodominant epitope of the HIV-1 gp120 protein. A theoretical study].
    Andrianov AM; Akhrem AA
    Biofizika; 1999; 44(1):10-7. PubMed ID: 10330579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein.
    Autiero M; Abrescia P; Dettin M; Di Bello C; Guardiola J
    Virology; 1991 Dec; 185(2):820-8. PubMed ID: 1720590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenicity of three synthetic peptides from the C-terminus of HIV-1 gp 120 correlates with the fragmentation pattern obtained in FAB mass spectrometry.
    Streckert HJ; Weber C; Müller D
    Intervirology; 1993; 36(3):128-33. PubMed ID: 7512081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational preferences of the HIV-1 principal neutralizing determinant.
    Andrianov AM
    J Biomol Struct Dyn; 2005 Dec; 23(3):267-82. PubMed ID: 16218754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the solution conformations of a human immunodeficiency virus peptidomimetic and its retro-inverso isomer using 1H NMR spectroscopy.
    Higgins KA; Bicknell W; Keah HH; Hearn MT
    J Pept Res; 1997 Dec; 50(6):421-35. PubMed ID: 9440043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Theoretical study of peptide spatial structure--fragments of the base antigenic determinant of HIV-1 gp120 protein. II. Hexapeptide Gly-Pro- Gly-Arg-Ala-Phe].
    Andrianov AM
    Mol Biol (Mosk); 1997; 31(5):872-9. PubMed ID: 9454073
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis and conformational studies of N-glycosylated analogues of the HIV-1 principal neutralizing determinant.
    Laczkó I; Hollósi M; Urge L; Ugen KE; Weiner DB; Mantsch HH; Thurin J; Otvös L
    Biochemistry; 1992 May; 31(17):4282-8. PubMed ID: 1567873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infection.
    Zanotto C; Calderazzo F; Dettin M; Di Bello C; Autiero M; Guardiola J; Chieco-Bianchi L; De Rossi A
    Virology; 1995 Feb; 206(2):807-16. PubMed ID: 7856094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and CD4 binding studies of a fluorescent analogue of a peptide that enhances HIV-1 infectivity.
    Dettin M; Scarinci C; Zanotto C; Cabrelle A; De Rossi A; Di Bello C
    J Pept Res; 1998 Feb; 51(2):110-5. PubMed ID: 9516045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solution structure of the V3 loop of a Thailand HIV isolate.
    Gupta G; Anantharamaiah GM; Scott DR; Eldridge JH; Myers G
    J Biomol Struct Dyn; 1993 Oct; 11(2):345-66. PubMed ID: 8286061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solid-state NMR evidence for an antibody-dependent conformation of the V3 loop of HIV-1 gp120.
    Weliky DP; Bennett AE; Zvi A; Anglister J; Steinbach PJ; Tycko R
    Nat Struct Biol; 1999 Feb; 6(2):141-5. PubMed ID: 10048925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure and polymorphism of the principal neutralization site of Thailand HIV-1 isolate.
    Andrianov AM; Sokalov YA
    J Biomol Struct Dyn; 2003 Feb; 20(4):603-13. PubMed ID: 12529159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.